Viewing Study NCT05448950


Ignite Creation Date: 2025-12-24 @ 5:14 PM
Ignite Modification Date: 2026-01-10 @ 12:38 AM
Study NCT ID: NCT05448950
Status: COMPLETED
Last Update Posted: 2024-12-04
First Post: 2022-07-04
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Continued Access Study VIG Anastomotic Connector
Sponsor: Phraxis, Inc.
Organization:

Study Overview

Official Title: Continued Access Study of the InterGraft™ Venous Anastomotic Connector for Minimally Invasive Connection of an Arteriovenous Graft for Hemodialysis
Status: COMPLETED
Status Verified Date: 2024-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: VIG-CAS
Brief Summary: The continued access study of the InterGraft Venous Anastomotic Connector (Venous InterGraft Continued Access Study, or 'VIG-CAS') allows for continued enrollment of subjects while the marketing application is being prepared and subsequently reviewed by FDA. The VIG-CAS will include the same patient population, follow-up schedule, and study endpoints as the VIG pivotal study.
Detailed Description: The VIG-CAS is a multicenter, prospective, single-arm study that will include up to 15 subjects contributed from up to 5 study sites that previously participated in the VIG pivotal study. No new investigators will be included. All subjects will be assigned to treatment with the VIG and a standard sutured arterial anastomosis for implantation of an arteriovenous graft (AVG) for hemodialysis. The selection criteria (patient population), follow-up schedule, and study endpoints are the same as those used in the pivotal study.

Study data will be collected up to the point at which each subject has completed the final 6-month follow up or experienced a terminal study event.

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: True
Is an Unapproved Device?: True
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: